BSE Live
Feb 06, 16:01Prev. Close
352.35
Open Price
355.60
Bid Price (Qty.)
348.50 (36)
Offer Price (Qty.)
352.35 (1)
NSE Live
Feb 09, 09:16Prev. Close
349.55
Open Price
350.00
Bid Price (Qty.)
350.35 (29)
Offer Price (Qty.)
353.15 (29)
| Key Financial Ratios of Medicamen Biotech (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.49 | 0.11 | -5.88 | -1.04 | 3.59 | |
| Diluted EPS (Rs.) | 0.49 | 0.11 | -5.88 | -1.04 | 3.59 | |
| Cash EPS (Rs.) | 2.67 | 1.91 | -3.95 | 0.82 | 5.26 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 18.07 | 18.55 | 18.51 | 24.39 | 25.88 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 18.07 | 18.55 | 18.51 | 24.39 | 25.88 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 81.79 | 82.18 | 75.38 | 122.00 | 155.91 | |
| PBDIT/Share (Rs.) | 5.29 | 5.26 | -0.82 | 3.37 | 9.45 | |
| PBIT/Share (Rs.) | 3.08 | 3.45 | -2.67 | 1.54 | 7.71 | |
| PBT/Share (Rs.) | 0.13 | 0.20 | -5.74 | -0.78 | 5.46 | |
| Net Profit/Share (Rs.) | 0.46 | 0.11 | -5.80 | -1.00 | 3.52 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 6.46 | 6.39 | -1.08 | 2.75 | 6.05 | |
| PBIT Margin (%) | 3.77 | 4.19 | -3.54 | 1.26 | 4.94 | |
| PBT Margin (%) | 0.15 | 0.24 | -7.61 | -0.63 | 3.50 | |
| Net Profit Margin (%) | 0.56 | 0.12 | -7.69 | -0.82 | 2.25 | |
| Return on Networth / Equity (%) | 2.56 | 0.56 | -31.35 | -4.10 | 13.60 | |
| Return on Capital Employed (%) | 1.84 | 0.49 | -28.15 | -3.78 | 12.13 | |
| Return on Assets (%) | 0.64 | 0.14 | -7.55 | -1.19 | 3.96 | |
| Total Debt/Equity (X) | 1.17 | 0.92 | 1.07 | 0.64 | 0.41 | |
| Asset Turnover Ratio (%) | 113.29 | 113.42 | 98.10 | 145.88 | 175.62 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.08 | 0.92 | 0.88 | 0.96 | 0.99 | |
| Quick Ratio (X) | 0.78 | 0.64 | 0.56 | 0.69 | 0.52 | |
| Inventory Turnover Ratio (X) | 5.78 | 5.71 | 4.23 | 7.96 | 5.61 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 100.00 | 0.00 | 0.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 100.00 | 0.00 | 0.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 31.62 | 23.04 | 21.58 | 20.98 | 22.96 | |
| EV/Net Operating Revenue (X) | 0.41 | 0.31 | 0.34 | 0.21 | 0.19 | |
| EV/EBITDA (X) | 6.28 | 4.92 | -31.13 | 7.56 | 3.08 | |
| MarketCap/Net Operating Revenue (X) | 0.18 | 0.14 | 0.11 | 0.11 | 0.16 | |
| Retention Ratios (%) | 100.00 | 100.00 | 0.00 | 0.00 | 100.00 | |
| Price/BV (X) | 0.80 | 0.63 | 0.44 | 0.55 | 0.95 | |
| Price/Net Operating Revenue | 0.18 | 0.14 | 0.11 | 0.11 | 0.16 | |
| Earnings Yield | 0.03 | 0.01 | -0.72 | -0.08 | 0.14 |
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y